Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility Read more about Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
FENNEC PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE Read more about FENNEC PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares Read more about Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
Fennec Announces Closing of Public Offering Read more about Fennec Announces Closing of Public Offering
Fennec Announces Pricing of Public Offering Read more about Fennec Announces Pricing of Public Offering
Fennec Announces Proposed Public Offering of Common Shares Read more about Fennec Announces Proposed Public Offering of Common Shares
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™ Read more about Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™ Read more about Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate Read more about Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
